5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow Dyslipidaemias: new trials by email Literature Review of Dyslipidaemias trials Research Report on Dyslipidaemias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin 10mg atorvastatin, 80mg atorvastatin, GSK1292263 Placebo - Dyslipidaemias, Dyslipidemias | Phase 2 | Completed | GlaxoSmithKline | 287 | 2010-09-14 | 2019-07-16 |
| Study to Test GSK256073 in Patients With Dyslipidemia GSK256073, Placebo, Niaspan - Dyslipidaemias, Dyslipidemias | Phase 2 | Completed | GlaxoSmithKline | 80 | 2009-06-15 | 2019-12-05 |
| Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. GW856553 - Healthy Subjects, Dyslipidaemias | Phase 2 | Completed | GlaxoSmithKline | 66 | 2007-07-01 | 2012-06-06 |
| GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol GW501516 oral tablets - Dyslipidaemias, Dyslipidaemia | Phase 2 | Completed | GlaxoSmithKline | 424 | 2004-08-01 | 2017-05-30 |
| Dyslipidemia Study Investigating The Increase In "Good Cholesterol" GW590735, fenofibrate - Dyslipidaemias | Phase 2 | Completed | GlaxoSmithKline | 250 | 2003-11-01 | 2012-10-22 |
Dyslipidemias (4) · Atherosclerosis (1) · Hypertriglyceridemia (1)
Lipid Metabolism Disorders (5) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Dyslipidemias (1) · Hyperlipidemias (1) · Vascular Diseases (1)
(1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)methyl methanesulfonate (1) · 2-methyl-2-(4-(((4-methyl-2-(4-trifluoromethylphenyl)-thiazol-5-ylcarbonyl)amino)methyl)phenoxy)propionic acid (1) · 6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylprpyl)-3-pyridinecarboxamide (1) · 8-chloro-3-pentyl-1H-purine-2,6(3H,7H)-dione (1) · Atorvastatin (1) · Ezetimibe (1) · Fenofibrate (1) · GW 501516 (1) · Niacin (1) · WASH protein, Drosophila (1)
GlaxoSmithKline (5)
United States (3) · Belgium (1) · Canada (1) · Denmark (1) · Estonia (1) · Finland (1) · France (1) · Germany (1) · Lithuania (1) · Netherlands (1) · Norway (1) · Portugal (1) · Sweden (1) · United Kingdom (1)